The transcription factor, NFkB, plays a pivotal role in the coordinated transactivation of cytokine and adhesion molecule genes involved in atherosclerosis and lesion formation after vascular injury. We hypothesized that synthetic doublestranded DNA with high affinity for NFkB may be introduced as a 'decoy' cis element to bind the transcription factor, and block gene activation, resulting in an effective therapeutic agent for treating intimal hyperplasia. In vivo transfection of NFkB decoy oligodeoxynucleotides (ODN) into ballooninjured rat carotid artery resulted in the inhibition of neointimal formation at 14 days after injury as compared with vessels transfected with scrambled ODN (P Ͻ 0.01). It is of importance to note that in the vessels
Introduction
Intimal hyperplasia is the pathological process that underlies restenosis, atherosclerosis and vascular graft occlusion, and develops in large part as a result of vascular smooth muscle cell (VSMC) proliferation and migration. 1 A number of logical assumptions about the cellular mechanisms involved in this hyperplastic response have led to clinical trials of various therapeutic approaches to prevent or retard this process. Unfortunately, none of the interventions tested to date have proven to have clinical utility, despite their effectiveness in animal experiments. 2 This discrepancy between expectations and clinical results indicates that the biology of arterial hyperplasia in response to injury may be considerably more complex than originally perceived. Therefore, it is necessary to further investigate the fundamental cellular mechanisms involved in this response, and con- 1635-1642. tinue to seek information about targets for treatment of restenosis.
and VCAM-was markedly decreased in blood vessels transfected with NFkB decoy ODN compared with scrambled ODN, whereas balloon injury induced ICAM and VCAM expression in the neointimal area. More importantly, the migration of macrophages and T-lymphocytes into the neointima and media was significantly inhibited by NFkB decoy ODN as compared with scrambled ODN. Here, we demonstrated that in vivo transfer of NFkB decoy ODN successfully inhibited neointimal formation after balloon injury, accompanied by (1) induction of apoptosis through p53 upregulation, and (2) inhibition of local inflammatory actions through the downregulation of adhesion molecules. These results suggest that decoy treatment against NFkB provides a new therapeutic strategy to inhibit neointimal hyperplasia after angioplasty. Gene Therapy (2001)
Dysregulated apoptosis has been implicated as a pathogenic mechanism in a variety of human diseases, including vascular disorders. Recently, compelling evidence has demonstrated that apoptosis of VSMC is critically involved in the progression of atherosclerosis and may contribute to the instability of advanced atherosclerotic plaques. [3] [4] [5] [6] After angioplasty, the 'response to injury program' involves induction of VSMC proliferation, which may result in restenosis of the diseased vessel. In this case, apoptosis may aid the remodeling of the injured artery and prevent the development of restenosis. 3, [6] [7] [8] Although little is known about the mechanisms that regulate apoptotic pathways in VSMC, recent studies suggest that the transcription factor nuclear factor-B (NFB) plays a crucial role in the regulation of apoptosis. 9, 10 In situ detection of nuclear p65 and p50 has revealed NFB activity within human atheroma, eg in intimal VSMC but not in undiseased arteries. 11, 12 Moreover, NFB was induced in VSMC after arterial balloon injury.
13,14 NFB activity appears to be essential for the proliferation of VSMC, which was demonstrated by the selective inhibition of VSMC growth after transfer of the NFB inhibitor protein IBα in cultured VSMC. [15] [16] [17] On the other hand, one of the key events in the process of restenosis is migration and accumulation of bloodderived cells, such as macrophages. In vascular cells, NFB has been shown to regulate the expression of vascular adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1) as a part of the inflammatory response. [18] [19] [20] It is also known that neutralizing antibody to ICAM-1 inhibits intimal hyperplasia after balloon injury of the carotid artery in rats. 21 In this study, to evaluate the therapeutic benefit of inhibition of NFB in neointimal formation after balloon injury, we utilized synthetic double-stranded DNA with high affinity for NFB as a 'decoy' cis element to bind the transcription factor and to block the activation of genes. 22, 23 Here, we report the successful in vivo transfer of NFB decoy ODN to reduce neointimal thickening, providing a new therapeutic strategy for restenosis after angioplasty.
Results

Effect of NFB decoy ODN on neointimal formation after balloon injury
We first measured the binding activity of NFB in the rat carotid artery after balloon injury, using gel mobility shift assay. Six hours after balloon injury, the binding activity of NFB was markedly increased as compared with that in normal intact vessels. Moreover, complete competition for the increased binding of NFkB by an excess amount of NFkB decoy ODN, but not scrambled decoy ODN, was observed (Figure 1 ), consistent with a previous report. 24 Therefore, we transfected NFkB decoy ODN into balloon- Figure 1 Nuclear NFB mobilization determined by gel mobility shift assay. Lane injured vessels. As expected, the binding activity of NFkB was markedly diminished in the blood vessels transfected with NFkB decoy ODN as compared with scrambled decoy ODN (Figure 1 ). These results confirm the successful inhibition of NFB binding activity by NFkB decoy ODN transfer.
Next, we examined the effect of transfection of NFkB decoy ODN into balloon-injured blood vessels on neointimal formation at 2 weeks after transfection (Figure 2a and b). It should be noted that a single transfection of NFkB decoy ODN into balloon-injured vessels resulted in a significant decrease in neointimal area as compared with scrambled decoy ODN (P Ͻ 0.01, Figure 2c ). Similarly, the ratio of neointimal to medial area in blood vessels transfected with NFB decoy ODN was also significantly decreased as compared with that in vessels transfected with scrambled decoy ODN and untransfected vessels (Figure 2e ; n = 10 for each group, P Ͻ 0.01). In contrast, there was no significant difference in the total vessel area or medial area among the treatment groups ( Figure 2d ). The specificity of the inhibitory effect of NFkB decoy ODN on neointimal formation after balloon injury was confirmed by the observation that transfection of AP-1 decoy ODN did not affect neointimal formation (Figure 2c and e).
Effect of NFB decoy ODN transfection on migration of macrophages and T-lymphocytes in blood vessels
Given the inhibitory effect of NFkB decoy ODN on neointimal formation, we elucidated the molecular mechanisms through which NFkB regulates neointimal formation after vascular injury. From this viewpoint, we focused on adhesion molecules, as it is known that NFkB regulates the expression of ICAM-1 and VCAM-1, [18] [19] [20] whose expression is increased in vascular cells after balloon injury. 15, 25 Upregulation of these adhesion molecules is considered to be closely implicated in neointimal thickening after arterial injury. Therefore, we investigated whether the expression of these molecules is altered by NFB decoy ODN transfection.
Three days after injury, expression of ICAM-1 was mainly observed in the surface and medial area. As expected, the expression of ICAM-1 was slightly lower in vessels transfected with NF-B decoy ODN than in vessels transfected with scrambled decoy ODN at 3 days after vascular injury (Figure 3a and b) . However, at 7 days after injury, the inhibitory effect of NFB decoy ODN on the expression of ICAM-1 was markedly observed (Figure 3c and d) . On the other hand, the expression of VCAM-1 was also markedly increased at both 3 and 7 days after injury ( Figure 4 ). The expression of VCAM-1 was reduced by transfection of NFB decoy ODN as compared with vessels transfected with scrambled decoy ODN, up to 7 days after vascular injury ( Figure 4) .
It is well known that the expression of adhesion molecules such as ICAM and VCAM leads to migration and accumulation of leukocytes. Local inflammatory actions including migration of leukocytes persist up to 30 days after balloon injury, and apparently contribute to the later phases of neointimal thickening. 25 As described above, transfection of NFB decoy ODN effectively inhibited the expression of ICAM-1 and VCAM-1 after balloon injury. Then, we investigated whether NFB decoy ODN transfer blocks migration of macrophages and T-lymphocytes into balloon-injured vessels. As expected, NFB, but not scrambled, decoy ODN markedly inhibited migration of macrophages and T-lymphocytes into the neointimal and medial areas ( Figure 5 , Table 1 ). These results may explain the mechanisms of the inhibitory effect of NFB decoy ODN on neointimal thickening after balloon injury, given that migration of macrophages and lymphocytes plays a pivotal role in the development of restenosis after balloon injury.
Figure 3 Effects of NFB decoy transfection on expression of ICAM-1 in rat carotid artery 3 or 7 days after balloon injury. Examples of immunohistochemical staining of serial sections for ICAM-1 are shown. Original magnification × 200. Left panel, scrambled decoy-transfected artery at 3 days (upper) or 7 days (lower) after balloon injury. Right panel, NFB decoy-transfected artery at 3 days (upper) or 7 days (lower) after balloon-injury.
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Effect of transfection of NFB decoy ODN on apoptosis in balloon-injured vessels
Recently, NFkB has been suggested to play an important role in apoptosis in vascular cells. However, no reports have described the role of NFkB in vascular apoptosis in vivo. Therefore, we finally, investigated the cross-talk between NFB activity and apoptosis in balloon-injured blood vessels. In this study, we counted TUNEL-positive cells in arteries after balloon injury as a marker of apoptosis. In vessels harvested 7 days after injury, few TUNEL-positive cells were observed in the neointimal and medial areas ( Figure 6 ). However, in blood vessels transfected with NFkB decoy ODN, many TUNEL-posi- tive cells (probably VSMC) were clearly observed, mainly in the neointimal area. Interestingly, a significant increase in apoptotic cells in the neointimal area was observed in vessels transfected with NFB decoy ODN as compared with scrambled decoy ODN (NFB; 65.8 + 10.2%, versus scrambled; 33.9 + 6.3%, P Ͻ 0.01). It is still unclear how NFB decoy ODN transfection increased apoptosis in the neointimal area observed in this study. Recently, it was reported that the p65 component (Rel A) of NFB and p53, an inducer of apoptosis, mutually repress each other's ability to activate transcription. 26 Therefore, it is possible that expression of p53 is increased in blood vessels transfected with NFB decoy, potentially leading to promotion of apoptosis in the neointimal area after balloon injury. Therefore, we investigated whether the expression of p53 is altered by NFB decoy ODN transfection. Seven days after injury, the protein of p53 was markedly increased in vessels transfected with NFB decoy ODN as compared with that in vessels transfected with scrambled decoy ODN (Figure 7) . A significant increase in p53-positive cells in the neointimal area was observed in vessels transfected with NFB decoy ODN as compared with scrambled decoy ODN (NFB; 58.8 + 12.3%, versus scrambled; 5.3 + 3.1%, P Ͻ 0.01).
Figure 5 Effects of NFB decoy transfection on migration of macrophages and T lymphocytes in neointima. Examples of immunohistochemical analysis of UCHL (T-lymphocytes) or CD68 (macrophage) in arteries at
Discussion
The family of various complexes of NFB transcription factor plays an important role in the transcription of a variety of genes, primarily those related to inflammation, interleukins, adhesion molecules, etc.
27,28 NFB complex is a heterodimer of two subunits, p50 and p65. In its inactive form in the cytoplasm, the complex is associated with an inhibitory subunit, IB. Subunit p65 has the capacity for potent transactivation of the target genes and is able to bind IB. 29, 30 NFB is activated by a variety of cytokines, endotoxins and oxidative stress. On activation, NFB dissociates from its inhibitor, IB, translocates to the nucleus and initiates transcription of various genes for cytokines, growth and differentiation factors. Numerous genes driven by NFB, ie interleukin-1 and -6, TNF-α and leukocyte adhesion molecules, 31 are involved in immune and inflammatory responses. Indeed, we have previously reported that inhibition of NFkB activity by decoy abolished the transactivation of IL-1 and IL-6 under TNF-α stimulation in human aortic endothelial cells. 32 Similarly, in cultured VSMC, inhibition of NFkB by transfer of purified IB inhibited not only VSMC proliferation, but also migration and adhesion. [15] [16] [17] Recently, it was reported that the increase in nuclear binding was transient (peak at 6 h after injury) and returned to the control level at 3 days after injury.
14 If such a rapid and transient activation of NFB after balloon injury plays a crucial role in the formation of neointima, inhibition of transient NFB activation should be a new therapeutic strategy. To block NFkB activation, we utilized a 'decoy' cis element, since decoy ODN can bind NF-B and thereby block its activation. Using this technology, we have already reported the successful inhibition of NFB activation in a rat myocardial infarction model. 24 Therefore, we examined the inhibition of NFB activation after balloon injury by in vivo transfection of NFkB decoy ODN into balloon-injured blood vessels. As expected, it was observed that activation of NFB in the injured vessels was successfully inhibited by NFB, but not scrambled, decoy ODN in vivo.
The present data reveal the importance of NFkB activation in neointimal formation after vascular injury, since transfection of NFkB decoy ODN inhibited neointimal formation accompanied by a decrease in NFkB activity. We found that inhibition of NFB activity resulted in potent inhibition of the expression of adhesion molecules such as ICAM and VCAM up to 7 days after injury. Since a recent paper reported the inhibitory effect of ICAM-1 antibody on neointimal thickening following balloon injury, 21 the inhibitory effect of NFkB decoy ODN might be due to a decrease in targeted genes, especially ICAM and VCAM. Moreover, we investigated the migration of macrophages and T-lymphocytes after injury, as migration of these cells is believed to be mediated by ICAM-1 and VCAM-1 expression. Importantly, the present data demonstrated that transfection of NFB, but not scrambled, decoy ODN significantly inhibited the migration and accumulation of macrophages and T-lymphocytes in the neointima following balloon injury. These results may explain the mechanisms of the inhibitory effect of NFB decoy ODN on neointimal thickening after balloon injury. In addition, our previous report documented the inhibition of other cytokines such as interleukin-6 by NFkB decoy ODN. 32 Probably, the inhibition of these adhesion molecules and cytokines by NFKB decoy ODN may have contributed to the inhibition of migration of immune cells.
Recently, it has been reported that a fundamental pathological feature of vascular disease is the marked abnormal accumulation of cells within the intimal space, resulting in neointimal lesion formation produced by alterations in the homeostatic balance between cell growth and cell death. 1 Interestingly, apoptosis in the neointima transfected with NFB decoy ODN was significantly increased as assessed by TUNEL staining. These results may have overestimated the rate of apoptosis, since TUNEL staining interfered with RNA synthesis and splicing, cell proliferation and necrosis. Although it is interesting that activity of NFB is associated with percentage of apoptosis in the neointima following injury, how inhibition of NFB increases apoptosis in blood vessels remains to be determined. From this viewpoint, p53 (p53 tumor suppressor gene) should be important, as p53 has been postulated to be a key regulator in the cell cycle and apoptosis in VSMC. [33] [34] [35] The presence of a functional p53 protein has been implicated as a critical determinant to regulate DNA replication, DNA repair and programmed cell death, 35 especially as p53 can induce apoptosis through bcl-2-dependent and -independent pathways. 36, 37 Our immunohistochemical analysis revealed that p53 expression in neointimal cells was much higher in vessels transfected with NFB decoy ODN than in those transfected with scrambled decoy ODN. Recently, the p65 component of NFB has been reported to mutually repress p53 transcription. 26 It is probable that inhibition of NFkB activity enhances p53, an inducer of apoptosis, in neointimal VSMC. This observation is consistent with recent in vitro experiments showing that NFB regulates induction of apoptosis in VSMC. [15] [16] [17] Since the time course of apoptosis seems to parallel cell proliferation after vascular injury, 6 induction of apoptosis is suggested to contribute toward vascular wound regression. 38 In addition, cell proliferation may be inhibited by NFkB decoy ODN. To overcome the limitation of the use of the rat model as the restenosis model, Gene Therapy we currently employ a porcine coronary artery model. Our preliminary data demonstrated that NFkB decoy ODN inhibited the increase in PCNA-positive cells induced by angioplasty. Further studies might answer the mechanisms of the inhibition of neointimal formation by NFkB decoy ODN.
Here, we demonstrated that in vivo transfection of NFB decoy ODN into balloon-injured blood vessels effectively suppressed activation of NFB induced by balloon injury and neointimal formation in a rat carotid artery model. NFkB decoy treatment also inhibited both ICAM-1 and VCAM-1 expression after balloon injury, leading to the inhibition of migration and accumulation of macrophages and T-lymphocytes into the neointima. Furthermore, inhibition of NFB activity increased apoptosis in the neointima after balloon injury, probably through p53 upregulation. These results suggest that in vivo transfection of a 'decoy' cis element to bind the critical transcription factor NFB may provide a new therapeutic model as gene therapy against restenosis after angioplasty, although a number of important issues, such as safety and side-effects, have not been addressed in this study. NFB decoy and AP-1 decoy ODN have been shown to bind the NFB and AP-1 transcription factor, respectively. 24, 39 Synthetic ODN were washed with 70% ethanol, dried and dissolved in sterile Tris-EDTA buffer (10 m Tris, 1 m EDTA). The supernatant was purified over a NAP 10 column (Pharmacia, Piscataway, NJ, USA) and quantified by spectrophotometry.
Materials and methods
Synthesis of ODN
Preparation of HVJ-liposome
The procedure used for the preparation of HVJ-liposome was previously described. 24, [39] [40] [41] [42] In brief, phosphatidylserine, phosphatidylcholine and cholesterol were mixed in a weight ratio of 1:4. The liposome suspension (0.5 ml, containing 10 mg lipid) was mixed with HVJ (10 000 hemagglutinating units) in a total volume of 4 ml BSS). The mixture was incubated at 4 o C for 5 min and then for 30 min with gentle shaking at 37 o C. Free HVJ was removed from the HVJ-liposome complex by sucrose density gradient centrifugation. The top layer of the sucrose gradient was collected for use. The final concentration of decoy ODN was equivalent to 15 m, as calculated according to previous reports. 24, [39] [40] [41] [42] This preparation method has been optimized to achieve maximal transfection efficiency.
Gel mobility shift assay
Nuclear extracts from balloon-injured and control carotid arteries of three animals (each group) were prepared as described. 24, 39 In brief, the arteries were homogenized with a Potte-Elvehjem homogenizer in four volumes of ice-cold homogenization buffer (10 mm Hepes pH 7.5, 0.5 m sucrose, 0.5 mm spermidine, 0.15 mm spermin, 5 mm EDTA, 0.2 m EGTA, 7 mm β-mercaptoethanol, 1 mm phenylmethylsulfonyl-fluoride). After centrifugation at 12 000 g for 30 min at 4 o C, the pellet was lysed and homogenized in one volume of ice-cold homogenization buffer containing 0.1% NP-40 in a Dounce homogenizer. Then the mixture was centrifuged at 12 000 g for 30 min at 4 o C and the pelleted nucleus was washed twice with ice-cold buffer containing 0.35 m sucrose. After washing, the nucleus was pre-extracted with one volume of ice-cold homogenization buffer containing 0.05 m NaCl and 10 % glycerol for 15 min at 4 o C. The nucleus was extracted with homogenization buffer containing 0.3 m NaCl and 10% glycerol for 1 h at 4 o C and the concentration of DNA was adjusted to 1 mg/ml. After pelleting the nuclear extract at 12 000 g for 30 min at 4 o C, the supernatant was brought to 45% (NH 4 ) 2 SO 4 and stirred for 30 min at 4 o C. The precipitated protein was collected at 17 000 g for 30 min, resuspended in homogenization buffer containing 0.35 m sucrose, and stored in aliquots at -70 o C. NFkB ODN were labeled as a probe at the 3' end by 3' endlabeled kit (Clontech, Palo Alto, CA, USA). After endlabeling, 32 P-labeled ODN were purified by nick column (Pharmacia LKB Biotechnology, CA, USA). The binding reaction (10 l) containing 32 P-labeled probe (0.5-1 ng, 10 000-15 000 c.p.m) and 1 g polydeoxyinosinic-deoxycytidic acid (Sigma Chemical, St Louis, MO, USA) was incubated with nuclear extract for 30 min at room temperature and then loaded on to a 5% polyacrylamide gel. The gels were subjected to electrophoresis and drying, and analyzed by autoradiography. For the competition assay, unlabeled double-stranded NFkB or scrambled decoy ODN were pre-incubated with a parallel sample 10 min before the addition of the labeled probe.
In vivo transfer into intact rat carotid artery
Male Sprague-Dawley rats (400-500 g; Charles River Breeding Laboratories, Tokyo, Japan) were anesthetized with ketamine, and the left common carotid artery was surgically exposed. 40, 41 A cannula was introduced into the common carotid artery via the external carotid artery. In vivo gene transfer was performed under the following conditions: vascular injury of the common carotid was produced by the passage and inflation of a balloon catheter (2 French Fogarty catheter) through an arteriotomy in the external carotid artery, three times. The injured segment was transiently isolated by temporary ligatures.
Then, 200 l HVJ-liposome complexes containing ODN was incubated within the lumen for 10 min. Two weeks after injury and transfection, each carotid artery was processed for determination of NFkB activity and morphological study (each group contained between seven and eight animals). For histological analyses, a segment of each artery was perfusion-fixed with 4% paraformaldehyde and subsequently processed. The arterial sections were evaluated quantitatively using an image analyzer. Three sections spaced at 3 mm per artery (a total of nine sections in each group) were examined. Medial and lumen areas were measured on a digitizing tablet (Power Lab) after staining with hematoxylin. The medial area was readily demarcated as the vessel area between the internal and external elastic laminae. At least three individual sections from the middle of the transfected arterial segments were analyzed. Animals were coded, so that the analysis was performed with no knowledge of which treatment each individual animal received.
In situ end labeling of fragmented DNA Sections from between four and six animals (each group) were deparaffinized, rehydrated, treated with proteinase K (20 g/ml), and incubated with PBS containing 0.3% hydrogen peroxide to reduce endogenous peroxidase activity. The method for nick end-labeling of apoptotic cells was adapted from that of Gavrieli et al 43 using a commercial kit (Oncor, Gaithersburg, MD, USA). It is based on the preferential binding of digoxigenin-dUTP by terminal deoxynucleotidyl transferase (TdT) to 3Ј-OH end-labeling (TUNEL) and was then detected by an antidigoxigenin antibody conjugated with peroxidase, a reporter enzyme that catalytically generates a brown-colored product from the chromogenic substrate diaminobenzidine (DAKO, Carpenteria, CA, USA). Counterstaining was performed by immersing the slides in 0.5% methyl green in 0.1 m sodium acetate solution (pH 4.0) for 5 min at room temperature.
Immunocytochemistry
Sections from between four and six animals (each group at each time point) were dewaxed, rehydrated, and incubated with PBS containing 0.3% hydrogen peroxide to reduce endogenous peroxidase activity. The sections were then incubated with primary antibodies or lectin, diluted in PBS with 10% horse serum, at room temperature for 60 min. After washing three times in Tris-buffered saline containing 2% horse serum, species-appropriate biotinylated secondary antibodies were applied followed by avidin-biotin peroxidase complex (Vectastain ABC kit, PK 6100; Vector Laboratories, Burlingame, CA, USA). Antibody binding was visualized with diaminobenzidine. Omission of primary antibodies and staining with type-and class-matched irrelevant immunoglobulin served as a negative control for each antibody.
A monoclonal antibody for CD68 (mouse IgG; DAKO) recognizes human and rat macrophages. A monoclonal antibody for UCHL1 (mouse IgG; DAKO) recognizes human and rat T-lymphocytes. A monoclonal antibody for p53 (mouse IgG; Calbiochem, La Jolla, CA, USA) recognizes rat p53. A polyclonal antibody for ICAM-1 recognizes rat and mouse ICAM-1 (goat IgG; Santa Cruz Co, Santa Cruz, CA, USA). A polyclonal antibody for VCAM-1 recognizes rat and mouse VCAM-1 (goat IgG; Santa Cruz).
Statistical analysis
All values are expressed as mean ± s.e.m. Analysis of variance with subsequent Dunnet's test was used to determine the significance of differences in multiple comparisons. P Ͻ 0.05 was considered significant. All experiments were carried out at least three times.
